person

Ephrem S.

Country
France
Department
Hepatobiliary and Transplantation Service

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
10
Sites with multiple studies

Has run more than one trial at 10 of 20 partner sites.

Specializations

Liver Cancer Research

The investigator specializes in treating advanced hepatocellular carcinoma (HCC), with particular focus on therapeutic approaches for patients with non-resectable conditions. Their research encompasses innovative treatment strategies for liver cancer patients awaiting transplantation.

  • Advanced HCC Management
  • Non-resectable Tumor Treatment
  • Post-TACE Therapy

Their work includes evaluating lenvatinib treatment efficacy in patients who have experienced TACE failure.

Transplant Medicine

The investigator focuses on liver transplantation procedures and post-transplant care, with expertise in managing immunosuppressive therapies. Their work includes developing optimized treatment protocols for transplant recipients.

  • Transplant Recipient Care
  • Immunosuppressive Strategies
  • Post-Transplant Monitoring

Their research involves studying single daily dose immunosuppressive regimens to improve patient outcomes after liver transplantation.

Immunotherapy Applications

The investigator studies combination immunotherapy approaches in transplant patients, particularly focusing on the application of atezolizumab and bevacizumab in liver transplant recipients with recurrent HCC.

  • Transplant Immunology
  • Cancer Immunotherapy
  • Graft Rejection Prevention

Their research evaluates the safety of immunotherapy combinations while maintaining appropriate immunosuppression levels.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.